Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Little Green Pharma Ltd. ( (AU:LGP) ) has provided an update.
Little Green Pharma has notified the ASX of a proposed large-scale issue of securities, comprising up to 202,528,681 convertible share rights and 511,068,667 fully paid ordinary shares, with a proposed issue date of 1 May 2026. The capital raising, structured as a placement or similar issue, signals a significant potential expansion of the company’s equity base, which could support future growth initiatives but may also lead to substantial shareholder dilution depending on final terms and uptake.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd is an ASX-listed company in the pharmaceuticals sector, focused on developing and supplying medicinal cannabis products. Its operations are centred on the cultivation, manufacture and distribution of cannabis-based medicines for patients in regulated markets.
Average Trading Volume: 192,812
Technical Sentiment Signal: Sell
Current Market Cap: A$36.68M
For an in-depth examination of LGP stock, go to TipRanks’ Overview page.